Skip to main content

Umbrella menu

  • SfN.org
  • eNeuro
  • The Journal of Neuroscience
  • Neuronline
  • BrainFacts.org

Main menu

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Latest Articles
    • Issue Archive
    • Editorials
    • Research Highlights
  • TOPICS
    • Cognition and Behavior
    • Development
    • Disorders of the Nervous System
    • History, Teaching and Public Awareness
    • Integrative Systems
    • Neuronal Excitability
    • Novel Tools and Methods
    • Sensory and Motor Systems
  • ALERTS
  • FOR AUTHORS
  • EDITORIAL BOARD
  • BLOG
  • ABOUT
    • Overview
    • For the Media
    • Privacy Policy
    • Contact Us
    • Feedback
  • SfN.org
  • eNeuro
  • The Journal of Neuroscience
  • Neuronline
  • BrainFacts.org

User menu

  • My alerts

Search

  • Advanced search
eNeuro
  • My alerts

eNeuro

Advanced Search

Submit a Manuscript
  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Latest Articles
    • Issue Archive
    • Editorials
    • Research Highlights
  • TOPICS
    • Cognition and Behavior
    • Development
    • Disorders of the Nervous System
    • History, Teaching and Public Awareness
    • Integrative Systems
    • Neuronal Excitability
    • Novel Tools and Methods
    • Sensory and Motor Systems
  • ALERTS
  • FOR AUTHORS
  • EDITORIAL BOARD
  • BLOG
  • ABOUT
    • Overview
    • For the Media
    • Privacy Policy
    • Contact Us
    • Feedback
PreviousNext
Research ArticleNew Research, Neuronal Excitability

Excitation of Diverse Classes of Cholecystokinin Interneurons in the Basal Amygdala Facilitates Fear Extinction

Laura Rovira-Esteban, Ozge Gunduz-Cinar, Olena Bukalo, Aaron Limoges, Emma Brockway, Kinga Müller, Lief Fenno, Yoon Seok Kim, Charu Ramakrishnan, Tibor Andrási, Karl Deisseroth, Andrew Holmes and Norbert Hájos
eNeuro 21 October 2019, 6 (6) ENEURO.0220-19.2019; DOI: https://doi.org/10.1523/ENEURO.0220-19.2019
Laura Rovira-Esteban
1Laboratory of Network Neurophysiology, Institute of Experimental Medicine, Hungarian Academy of Sciences, Budapest 1083, Hungary
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Laura Rovira-Esteban
Ozge Gunduz-Cinar
2Laboratory of Behavioral and Genomic Neuroscience, National Institute on Alcohol Abuse and Alcoholism, NIH, Bethesda, MD 20814
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Olena Bukalo
2Laboratory of Behavioral and Genomic Neuroscience, National Institute on Alcohol Abuse and Alcoholism, NIH, Bethesda, MD 20814
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aaron Limoges
2Laboratory of Behavioral and Genomic Neuroscience, National Institute on Alcohol Abuse and Alcoholism, NIH, Bethesda, MD 20814
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Emma Brockway
2Laboratory of Behavioral and Genomic Neuroscience, National Institute on Alcohol Abuse and Alcoholism, NIH, Bethesda, MD 20814
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kinga Müller
1Laboratory of Network Neurophysiology, Institute of Experimental Medicine, Hungarian Academy of Sciences, Budapest 1083, Hungary
3János Szentágothai Doctoral School of Neurosciences, Semmelweis University, Budapest 1085, Hungary
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lief Fenno
4Department of Bioengineering, Stanford University, Stanford, CA 94305
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yoon Seok Kim
4Department of Bioengineering, Stanford University, Stanford, CA 94305
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Charu Ramakrishnan
4Department of Bioengineering, Stanford University, Stanford, CA 94305
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Charu Ramakrishnan
Tibor Andrási
1Laboratory of Network Neurophysiology, Institute of Experimental Medicine, Hungarian Academy of Sciences, Budapest 1083, Hungary
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Karl Deisseroth
4Department of Bioengineering, Stanford University, Stanford, CA 94305
5Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, CA 94305
6Howard Hughes Medical Institute, Stanford University, Stanford, CA 94305
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrew Holmes
2Laboratory of Behavioral and Genomic Neuroscience, National Institute on Alcohol Abuse and Alcoholism, NIH, Bethesda, MD 20814
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Norbert Hájos
1Laboratory of Network Neurophysiology, Institute of Experimental Medicine, Hungarian Academy of Sciences, Budapest 1083, Hungary
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Norbert Hájos
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Figures & Data

Figures

  • Extended Data
  • Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1.

    Intersectional strategy for targeting BA INs. A, Schematic of the intersectional strategy used to target BA INs in CCK-Cre;Dlx5/6-Flp double-transgenic mice with (B) INTRSECT pAAV-nEF1a-Con/Fon-hChR2(H134R)-EYFP-WPRE virus. C, Representative example of EYFP expression after virus transfection (scale bar = 100 µm). D, Virus-transfected (EYFP-expressing) cells immunopositive for GAD67 (white arrows, scale bar = 10 µm). E, Virus-transfected (EYFP-expressing) cells labeled with Cck and Gad1 mRNA; arrows denote two example neurons positive for EYFP, Cck, and Gad1 (white arrows, scale bar = 10 µm).

  • Figure 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2.

    Photostimulation of GABAergic cells in the BA. A, Schematic drawing showing the intersectional viral strategy used to target CCK+ INs in CCK-Cre;Dlx5/6-FLP double-transgenic mice. B, Example of INTRSECT AAVdj-hSyn-Con/Fon-hChR2(H134R)-EYFP-WPRE (INTRSECT-ChR2) expression in the BA (CeA = central amygdala). C, Schematic drawing represents a horizontal slice with viral expression shown in green (Hip = hippocampus). Whole-cell patch clamp recordings were performed in non-green cells, likely in PNs in slices prepared from double-transgenic mice injected with AAV containing INTRSECT-ChR2. D, E, Averaged traces of five consecutive PSCs obtained in three different neurons evoked by light illumination (blue arrow). High variability both in peak amplitude (D) and decaying phase (D, E) is typical for events evoked in different neurons. The traces in E are peak scaled. Dashed lines show where the peak amplitude for fast and slow components of evoked currents was measured. F, Traces from an experiment measuring the antagonist-sensitivity of light-evoked responses. Gabazine (5 µM) wash-in eliminated the fast GABAA-mediated component, while CGP 5699A (1 µM) blocked the remaining slow GABAB-mediated component. Importantly, no inward, i.e., EPSC, could be observed in the presence of the GABA receptor antagonists, indicating that the applied intersectional strategy allowed us to excite selective GABAergic cells. G, Peak amplitude of the fast components in evoked responses measured in the same neurons was significantly larger than the peak amplitude of the slow components. H, The fast components were blocked by bath application of gabazine (*paired t test). I, The slow components were eliminated by CGP 5699A wash-in. J, The area, i.e., the charge of the fast and slow components evoked in the same neurons, was not different. GABAA receptor-mediated fast responses were isolated by subtracting the responses recorded in the presence of gabazine from the control traces and their area was measured. Example traces (subtracted) are shown in F. The area of the GABAB receptor-mediated slow components were determined on the traces recorded in the presence of gabazine. K, Averaged traces taken from an example experiment indicate that the light-evoked PSCs are smaller on wash-in of a CB1R agonist, CP 55,940 (2 µM). L, In all experiments tested, bath application of CP 55,940 significantly reduced the peak amplitude of the fast component. M, Averaged traces taken from an experiment showing that, in the presence of the CB1R antagonist, AM251 (2 µM), bath application of CP 55,940 (2 µM) did not cause a reduction in the peak amplitude. N, Preincubation of the slices in AM251 prevented the CP 55,940-induced reduction of the peak amplitude of light-evoked postsynaptic responses. O–Q, A portion of EYFP-expressing axon terminals is immunoreactive for CB1 (arrows). R, Approximately 40% of EYFP-expressing axonal varicosities were immunopositive for CB1R (156 EYFP+ varicosities were tested in two mice); *p < 0.05 fast versus slow, +gabazine versus control (Ctr), +CGP versus in gabazine (Gab), +CP versus Ctr. n.s., non-significant.

  • Figure 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 3.

    GABAergic cells labeled with intersectional viral strategy represent different populations of INs. A, Example of EYFP-expressing cells (panel A1) that either are (panel A2, arrow) or are not (panel A3, asterisk) also immunopositive for NPY (scale bar = 10 µm). B, Example of two EYFP-expressing cells (panel B1, arrow and arrowhead) that both contain PV (panel B2), but only one of which is also immunopositive for Calb (panel B3, arrow; scale bar = 10 µm). C, Pie chart showing the ratio of EYFP-expressing neurons that contain PV or NPY. Note a large proportion of cells does not express either PV or NPY. D, Example of EYFP-expressing cell (panel D1, asterisk) and non-overlapping cells immunopositive for CaMKII (panels D2, D3; scale bar = 10 µm).

  • Figure 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 4.

    Action potential features distinguish GABAergic cell types labeled with intersectional viral strategy. A, Schematic drawing depicts a horizontal slice with viral expression shown in green (Hip = hippocampus). Whole-cell patch clamp recordings were performed in INTRSECT-ChR2-transfected GABAergic cells (green circles) visualized by blue light illumination. B, Traces exemplifying differences in the full width at action potential half maximum (FWHM), 50% decay of AHP and maximum firing rate for the three electrophysiologically distinct IN groups: fast-spiking INs (FS INs) in orange, CCK+ basket cells (CCKBCs) in blue, and NGFCs in cyan. C, 3D plot showing the separation of 33 intracellularly labeled EYFP+ INs based on the three action potential parameters. D–G, Examples of four distinct types of EYFP-expressing INs intracellularly filled by whole-cell recording in vitro. In each case, a maximal intensity projection of a 3D confocal image of the labeled INs is shown together with its firing pattern and the EYFP expression at the soma level. D, An example for a PV+ basket cell (PVBC) identified based on its firing pattern, Calb and PV positivity in its axonal boutons (white arrows in insets) and forming no close appositions (red arrows) with ankyrin G (AnkG)-labeled axon initial segments (delimited by green arrowheads). E, An example for a PV+ axo-axonic cell (AAC) identified based on its firing pattern, PV positivity and Calb negativity in its axonal boutons (white arrows in insets) and forming close appositions by its axonal boutons (red arrows) with an AnkG-labeled axon initial segment (delimited by green arrowheads). F, An example for a CCKBC identified based on its firing pattern and on the CB1 content in its axonal boutons (white arrows in insets). G, An example of a NGFC based on its dendritic and axonal morphology and characteristic firing pattern. H, Pie chart showing the ratio of identified IN types in a group of EYFP-expressing neurons in the BA that were randomly sampled in slice preparations. For D–G depictions of maximal intensity projections of intracellularly filled cells, scale bar = 40 µm, insets = 5 µm; firing pattern scale bar x-axis = 100 ms, y-axis = 10 mV.

  • Figure 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 5.

    In vivo photostimulation of transfected INs during extinction training. A, Schematic of the intersectional strategy used to target BA INs in CCK-Cre;Dlx5/6-Flp double-transgenic mice with INTRSECT pAAV-nEF1a-Con/Fon-hChR2(H134R)-EYFP-WPRE or AAVdj-hSyn-Con/Fon-Arch3.3-EYFP-WPRE virus and shine blue or green light during each CS presentation of extinction-training. For fiber placement maps see Extended Data Figure 5-1. B, Photoexcitation, but not photoinhibition, during extinction training reduced freezing on light-free extinction retrieval the following day; n = 9–13 per group; *p < 0.05 INTRSECT-ChR2 versus INTRSECT-EYFP. #p < 0.05 T0 versus T1 extinction training for INTRSECT-ChR2.

  • Figure 6.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 6.

    In vivo photostimulation and photosilencing of transfected BA INs and PNs during extinction training. A, Schematic of approach to targeting BA INs and PNs in CCK-Cre single-transgenic mice with AAV5-Ef1a-DIO-hChR2(H134R)-EYFP-WRPE-pA or AAV5-Ef1a-DIO-eArch3.0-EYFP. B, Representative example of EYFP expression after virus transfection. C, Virus-transfected (EYFP-expressing) cells labeled with Cck mRNA, including example of cell labeled with Gad1 mRNA (white arrows, scale bar = 20 µm). D, Virus-transfected (EYFP-expressing) cells labeled with Cck mRNA, including example of cell labeled with Slc17a7 mRNA (white arrows, scale bar = 20 µm). E, Blue (ChR2 group) or green (eArch3.0 group) was shone during each CS presentation of extinction training. For fiber placement maps see Extended Data Figure 6-1. F, Photoexcitation in the ChR2 group during each CS presentation of extinction training increased freezing during training and light-free extinction retrieval the following day, relative to EYFP controls. Photosilencing in the eArch3.0 group during each CS presentation of extinction training reduced freezing on light-free extinction retrieval the following day, relative to EYFP controls; n = 12–27 per group; *p < 0.05, #p < 0.05 T0 versus T1 extinction training. Results of similar interventions on locomotion and anxiety level are presented in Extended Data Figure 6-2.

Extended Data

  • Figures
  • Extended Data Figure 5-1

    Virus expression and optic-fiber placement for CCK-Cre;Dlx5/6-FLP experiments. A, Representative INTRSECT-ChR2 virus localization in the BA. B, Cartoon depicting optic-fiber placements in the INTRSECT-ChR2 group. C, Representative INTRSECT-Arch virus localization in the BA. D, Cartoon depicting optic-fiber placements in the INTRSECT-Arch group. Download Figure 5-1, TIF file.

  • Extended Data Figure 6-1

    Virus expression and optic-fiber placements for CCK-Cre experiments. A, Representative ChR2 virus localization in the BA. B, Cartoon depicting optic-fiber placements in the ChR2 group. C, Representative eArch3.0 virus localization in the BA. D, Cartoon depicting optic-fiber placements in the eArch3.0 group. Download Figure 6-1, TIF file.

  • Extended Data Figure 6-2

    In vivo photostimulation and photosilencing of transfected BA INs and PNs during a novel open field test. A, Neither photoexcitation in the ChR2 group nor photosilencing in the eArch3.0 group altered total distance traveled, relative to EYFP controls. B, Neither photoexcitation in the ChR2 group nor photosilencing in the eArch3.0 group altered center zone distance traveled, relative to EYFP controls; n = 6–17 per group. Download Figure 6-2, TIF file.

Back to top

In this issue

eneuro: 6 (6)
eNeuro
Vol. 6, Issue 6
November/December 2019
  • Table of Contents
  • Index by author
Email

Thank you for sharing this eNeuro article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Excitation of Diverse Classes of Cholecystokinin Interneurons in the Basal Amygdala Facilitates Fear Extinction
(Your Name) has forwarded a page to you from eNeuro
(Your Name) thought you would be interested in this article in eNeuro.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
View Full Page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Citation Tools
Excitation of Diverse Classes of Cholecystokinin Interneurons in the Basal Amygdala Facilitates Fear Extinction
Laura Rovira-Esteban, Ozge Gunduz-Cinar, Olena Bukalo, Aaron Limoges, Emma Brockway, Kinga Müller, Lief Fenno, Yoon Seok Kim, Charu Ramakrishnan, Tibor Andrási, Karl Deisseroth, Andrew Holmes, Norbert Hájos
eNeuro 21 October 2019, 6 (6) ENEURO.0220-19.2019; DOI: 10.1523/ENEURO.0220-19.2019

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Respond to this article
Share
Excitation of Diverse Classes of Cholecystokinin Interneurons in the Basal Amygdala Facilitates Fear Extinction
Laura Rovira-Esteban, Ozge Gunduz-Cinar, Olena Bukalo, Aaron Limoges, Emma Brockway, Kinga Müller, Lief Fenno, Yoon Seok Kim, Charu Ramakrishnan, Tibor Andrási, Karl Deisseroth, Andrew Holmes, Norbert Hájos
eNeuro 21 October 2019, 6 (6) ENEURO.0220-19.2019; DOI: 10.1523/ENEURO.0220-19.2019
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Significance Statement
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
    • Synthesis
    • Author Response
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Keywords

  • basolateral amydala
  • emotional circuits
  • inhibitory cells
  • excitatory cells
  • mouse

Responses to this article

Respond to this article

Jump to comment:

No eLetters have been published for this article.

Related Articles

Cited By...

More in this TOC Section

New Research

  • SRF is required for maintenance of astrocytes in non-reactive state in the mammalian brain
  • Mapping sex-specific neurodevelopmental alterations in neurite density and morphology in a rat genetic model of psychiatric illness
  • Lytic cell death in specific microglial subsets is required for preventing atypical behavior in mice
Show more New Research

Neuronal Excitability

  • Subunit-specific photocontrol of glycine receptors by azobenzene-nitrazepam photoswitcher
  • Calmodulin Bidirectionally Regulates Evoked and Spontaneous Neurotransmitter Release at Retinal Ribbon Synapses
  • Cell-Type Specificity of Neuronal Excitability and Morphology in the Central Amygdala
Show more Neuronal Excitability

Subjects

  • Neuronal Excitability
  • Home
  • Alerts
  • Visit Society for Neuroscience on Facebook
  • Follow Society for Neuroscience on Twitter
  • Follow Society for Neuroscience on LinkedIn
  • Visit Society for Neuroscience on Youtube
  • Follow our RSS feeds

Content

  • Early Release
  • Current Issue
  • Latest Articles
  • Issue Archive
  • Blog
  • Browse by Topic

Information

  • For Authors
  • For the Media

About

  • About the Journal
  • Editorial Board
  • Privacy Policy
  • Contact
  • Feedback
(eNeuro logo)
(SfN logo)

Copyright © 2021 by the Society for Neuroscience.
eNeuro eISSN: 2373-2822

The ideas and opinions expressed in eNeuro do not necessarily reflect those of SfN or the eNeuro Editorial Board. Publication of an advertisement or other product mention in eNeuro should not be construed as an endorsement of the manufacturer’s claims. SfN does not assume any responsibility for any injury and/or damage to persons or property arising from or related to any use of any material contained in eNeuro.